BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1040 related articles for article (PubMed ID: 25632936)

  • 21. The role of lncRNAs in hepatocellular carcinoma: opportunities as novel targets for pharmacological intervention.
    Zou H; Shao CX; Zhou QY; Zhu GQ; Shi KQ; Braddock M; Huang DS; Zheng MH
    Expert Rev Gastroenterol Hepatol; 2016; 10(3):331-40. PubMed ID: 26558504
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Mechanism Underlying the ncRNA Dysregulation Pattern in Hepatocellular Carcinoma and Its Tumor Microenvironment.
    Xue C; Gu X; Bao Z; Su Y; Lu J; Li L
    Front Immunol; 2022; 13():847728. PubMed ID: 35281015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNAs: new tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma?
    Giordano S; Columbano A
    Hepatology; 2013 Feb; 57(2):840-7. PubMed ID: 23081718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional long non-coding RNAs in hepatocellular carcinoma.
    Xie C; Li SY; Fang JH; Zhu Y; Yang JE
    Cancer Lett; 2021 Mar; 500():281-291. PubMed ID: 33129957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-coding RNAs in hepatitis B or C-associated hepatocellular carcinoma: potential diagnostic and prognostic markers and therapeutic targets.
    Zhang Q; Pu R; Du Y; Han Y; Su T; Wang H; Cao G
    Cancer Lett; 2012 Aug; 321(1):1-12. PubMed ID: 22425745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long noncoding RNA network: Novel insight into hepatocellular carcinoma metastasis (Review).
    Zhu X; Pan H; Liu L
    Int J Mol Med; 2021 Jul; 48(1):. PubMed ID: 34013360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of miRNA sponges in hepatocellular carcinoma.
    Li D; Zhang J; Li J
    Clin Chim Acta; 2020 Jan; 500():10-19. PubMed ID: 31604064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epigenetic regulation in hepatocellular carcinoma requires long noncoding RNAs.
    Amicone L; Citarella F; Cicchini C
    Biomed Res Int; 2015; 2015():473942. PubMed ID: 25861629
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long Noncoding RNAs Act as Novel Biomarkers for Hepatocellular Carcinoma: Progress and Prospects.
    Bao H; Su H
    Biomed Res Int; 2017; 2017():6049480. PubMed ID: 28835896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long non-coding RNAs: critical players in hepatocellular carcinoma.
    Sun J; Bie B; Zhang S; Yang J; Li Z
    Int J Mol Sci; 2014 Nov; 15(11):20434-48. PubMed ID: 25387074
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular mechanisms of circular RNAs, transforming growth factor-β, and long noncoding RNAs in hepatocellular carcinoma.
    Shang W; Adzika GK; Li Y; Huang Q; Ding N; Chinembiri B; Rashid MS; Machuki JO
    Cancer Med; 2019 Nov; 8(15):6684-6699. PubMed ID: 31523930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circular RNAs in hepatocellular carcinoma: Biomarkers, functions and mechanisms.
    Qiu L; Xu H; Ji M; Shang D; Lu Z; Wu Y; Tu Z; Liu H
    Life Sci; 2019 Aug; 231():116660. PubMed ID: 31319086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decoding hepatocarcinogenesis from a noncoding RNAs perspective.
    El-Aziz MKA; Dawoud A; Kiriacos CJ; Fahmy SA; Hamdy NM; Youness RA
    J Cell Physiol; 2023 Sep; 238(9):1982-2009. PubMed ID: 37450612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long non-coding RNAs as novel targets for therapy in hepatocellular carcinoma.
    Parasramka MA; Maji S; Matsuda A; Yan IK; Patel T
    Pharmacol Ther; 2016 May; 161():67-78. PubMed ID: 27013343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of long noncoding RNA expression profile in oxaliplatin-resistant hepatocellular carcinoma cells.
    Yin X; Zheng SS; Zhang L; Xie XY; Wang Y; Zhang BH; Wu W; Qiu S; Ren ZG
    Gene; 2017 Jan; 596():53-88. PubMed ID: 27729273
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-coding RNAs in hepatocellular carcinoma: Insights into regulatory mechanisms, clinical significance, and therapeutic potential.
    Han Q; Wang M; Dong X; Wei F; Luo Y; Sun X
    Front Immunol; 2022; 13():985815. PubMed ID: 36300115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Role of Long Non-Coding RNAs in Hepatocarcinogenesis.
    Lanzafame M; Bianco G; Terracciano LM; Ng CKY; Piscuoglio S
    Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495592
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long non-coding RNA HOTTIP is frequently up-regulated in hepatocellular carcinoma and is targeted by tumour suppressive miR-125b.
    Tsang FH; Au SL; Wei L; Fan DN; Lee JM; Wong CC; Ng IO; Wong CM
    Liver Int; 2015 May; 35(5):1597-606. PubMed ID: 25424744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting non-coding RNAs and N
    Wu L; Zhang Y; Ren J
    Biochem Pharmacol; 2024 May; 223():116153. PubMed ID: 38513741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNAs involved with hepatocellular carcinoma (Review).
    Mao B; Wang G
    Oncol Rep; 2015 Dec; 34(6):2811-20. PubMed ID: 26398882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 52.